Air pollution is a greater threat than tobacco, says doctor
Speaking at the event organised by the Indian Medical Association, Dr. Guleria urged the medical community to adopt the 'One Health' approach that integrates human, animal and environmental health.
'Air pollution is a silent killer,' Dr. Guleria said, citing recent studies that attribute 8.1 million deaths globally in 2021 to air pollution, a toll greater than that of COVID-19. He said the rise of non-communicable diseases such as cancer, diabetes, and cardiovascular disorders has overtaken communicable diseases as the dominant health burden in India, particularly in southern States. 'Air pollution is now among the top three causes of death and disability globally, and we are not paying enough attention,' he said.
Highlighting how particulate matter smaller than 2.5 micrometres can penetrate deep into the lungs and bloodstream, Dr. Guleria explained its link to a range of diseases, including asthma, strokes, dementia, low birth weight, and even osteoporosis in postmenopausal women. 'We now have evidence that air pollution is linked to type 1 and type 2 diabetes, reproductive issues and even spontaneous abortions,' he said.
He also drew attention to the disproportionate impact of poor air quality in Indian cities. He referred to a recent study covering ten Indian cities, including Hyderabad, Mumbai, Varanasi and Shimla, that showed a 1.4% rise in daily mortality associated with PM2.5 exposure, even at pollution levels below India's current permissible standards.
'This is not a Delhi problem. It is a Hyderabad problem, a Varanasi problem, a Srinagar problem. The entire nation is breathing poison,' he said. He also warned that current Indian air quality standards are far above what the World Health Organization recommends, and called for urgent revision and implementation.
'Pandemics are not rare anymore. In the last 25 years, we have seen two global pandemics and several major outbreaks. This is directly tied to how we are treating the planet,' he said.
He concluded with a call for collaborative, multi-sectoral action. 'We need doctors, veterinarians, environmental scientists, urban planners, and policy-makers to work together. Without a unified approach, we will keep losing lives, silently and steadily to the air we breathe and the systems we ignore.'
The event was attended by Indian Medical Association (IMA) national president Dilip Bhanushali, IMA Telangana president Dwarkanath Reddy and AIG Hospital chairman D. Nageshwar Reddy among other senior doctors.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Deccan Herald
3 hours ago
- Deccan Herald
WHO to document Karnataka's 'Asha Kirana' as global eye care model
The World Health Organization (WHO) has expressed interest in Karnataka's 'Asha Kirana' initiative, which provides doorstep eye care, and plans to share its success story with other countries and regions. The WHO has proposed a comprehensive assessment of the initiative to further strengthen the programme and generate valuable insights and best practices for other regions aiming to implement integrated, people-centred eye care. In a letter to Harsh Gupta, Principal Secretary of Health and Family Welfare, WHO Representative to India, Dr Roderico H Ofrin, appreciated the state government for conceptualising and effectively implementing the 'Asha Kirana' initiative. "This innovative model, launched under your leadership, marks significant progress towards eliminating avoidable blindness and ensuring equitable access to comprehensive eye care across the state. We are particularly encouraged by how 'Asha Kirana' aligns with the WHO's Integrated People-Centred Eye Care (IPEC) framework," Ofrin wrote in the letter dated June 30. Recognising its impact and scalability, the WHO expressed keen interest in systematically documenting the state's model. Such an evaluation, Ofrin noted, will help strengthen the programme while providing lessons and best practices for other regions and countries.


The Hindu
3 hours ago
- The Hindu
Centre approves 100-bed yoga and naturopathy hospital in Guntur
The Central government has approved the establishment of a 100-bed hospital under the Central Research Institute of Yoga and Naturopathy (CRIYN) at Nadimpalem village in Prathipadu mandal of Guntur district, with a total outlay of ₹94 crore. Union Minister of State for Rural Development and Communications, Dr. Pemmasani Chandra Sekhar, on Thursday informed that the hospital will be built on 15 acres under the Ministry of AYUSH and will be fully funded by the Centre. The hospital will include modern medical facilities, a scientific research centre, a training institute, and residential quarters for medical staff. The project aims to offer round-the-clock integrated healthcare services, blending traditional Indian medicine with scientific research. Minister Pemmasani said the centre would serve as a national hub for research, training, and treatment in yoga and naturopathy, contributing to healthier lifestyles through traditional practices. He termed it as a major opportunity not just for Guntur but for entire Andhra Pradesh. He expressed gratitude to Prime Minister Narendra Modi, Union Minister of State (Independent Charge) of the Ministry of Ayush Jadhav Prataprao Ganpatrao, and the Central government, highlighting that the project is a milestone in Andhra Pradesh's healthcare development under Chief Minister N. Chandrababu Naidu's leadership.


NDTV
3 hours ago
- NDTV
Covid Vaccines Not Behind Sudden Deaths, Suggests Top Medical Body Study
New Delhi: None of the Covid vaccine doses are linked to heart attacks and deaths, said Dr Sudheer Arava from AIIMS, who is part of the research currently underway by the Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS). Speaking to IANS, he noted that preliminary data so far has shown no indication between heart attack and Covid jabs, developed in the country. "Till now, our study data says that the vaccine has no effect on the cause of death, whether it is a first dose, second dose or third dose, there is no difference in it," Arava added. His comments amid concerns over several heart attack deaths being seen in the country. About the study, Arava, from AIIMS' Department of Pathology, said that it was launched by the ICMR, in the aftermath of deaths happening in the country after the arrival of Covid. Initial results, soon to be published, indicate that 50 per cent of the deaths caused among individuals between 18 to 45 years are due to heart attacks. The other finding is "unexplained death, in which we could not ascertain the cause". Further, to understand whether the deaths match with those during pre-COVID days, they analysed previous data but found no difference in the cause of death. "We found out that the pattern of death rate among young individuals in pre-COVID times is similar to that of during COVID. We did not find any effect of the vaccine in this... There is no clear-cut indication saying that the vaccine causes sudden death in young individuals," Arava told IANS. "The benefits of vaccines far outweigh the very small possible side effects," added Dr Rajiv Narang from the Department of Cardiology, AIIMS. He added that "people should be aware that a heart attack is not a simple issue -- there can be many causes for sudden cardiac arrest". Meanwhile, the Indian Vaccine Manufacturers Association (IVMA) also issued a statement assuring the safety of the Covid vaccines developed in the country. "Covid-19 vaccines of India were developed and manufactured with the highest safety and quality standards," IVMA Director General, Dr G.V.J.A. Harshavardhan, said. "All Covid-19 vaccines in India were approved for Emergency Use Authorisation (restricted use in emergency situations of the WHO guidelines)," he added. Harshavardhan noted that the approvals were based on extensive evaluation in preclinical studies and human clinical trials. He stated that the Indian vaccines not only helped "control the Covid-19 pandemic and restrict its impact on lives, livelihoods, but most importantly, enabling India's economic activity and GDP to rebound and grow to new heights globally". Harshavardhan said that the benefits of India-made Covid jabs were also extended to several countries worldwide, under the government's Vaccine Maitri programme. "We hereby reassure the public on the safety and efficacy of Covid-19 vaccines," he said.